表紙:不妊治療の世界市場 - 2026年までの予測:製品別 (装置、培地、付属品)、処置別 (ART、人工授精)、患者タイプ別、エンドユーザー別
市場調査レポート
商品コード
1033054

不妊治療の世界市場 - 2026年までの予測:製品別 (装置、培地、付属品)、処置別 (ART、人工授精)、患者タイプ別、エンドユーザー別

Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure(ART (IVF,ICSI, Surrogate), Insemination, Laparoscopy, Hysteroscopy, Patient Type(Female, Male), End User(Fertility Clinics, Hospitals, Research) - Global Forecast -2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 248 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.84円
不妊治療の世界市場 - 2026年までの予測:製品別 (装置、培地、付属品)、処置別 (ART、人工授精)、患者タイプ別、エンドユーザー別
出版日: 2021年10月18日
発行: MarketsandMarkets
ページ情報: 英文 248 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の不妊治療の市場規模は、2021年の15億米ドルから、2026年までに22億米ドルに達し、予測期間中のCAGRで8.1%の成長が予測されています。

世界的な出生率の低下、さまざまな不妊治療法の普及、世界中の不妊治療クリニック数の増加、公共・民間投資の増加、先進的な不妊治療製品の存在などの要因が、市場の成長を後押しすると予想されます。

当レポートでは、世界の不妊治療市場について調査分析し、市場概要、業界動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 規制情勢
  • 不妊治療市場に対するCOVID-19の影響
  • バリューチェーン分析
  • 価格動向分析
  • ポーターのファイブフォース分析
  • エコシステムの範囲

第6章 不妊治療市場:製品別

  • 装置
  • 培地・消耗品
  • 付属品

第7章 不妊治療市場:処置別

  • ART
  • 人工授精
  • 妊孕性手術
  • その他

第8章 不妊治療市場:患者タイプ別

  • 女性
  • 男性

第9章 不妊治療市場:エンドユーザー別

  • 不妊治療センター
  • 病院・外科クリニック
  • 精子バンク
  • 研究機関

第10章 不妊治療市場:地域別

  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他のアジア太平洋地域
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • 北米
    • 米国
    • カナダ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他のラテンアメリカ
  • 中東・アフリカ

第11章 競合情勢

  • 概要
  • 主要企業の戦略
  • 主要市場企業の収益シェア分析
  • 市場シェア分析
  • 競合リーダーシップマッピング
  • スタートアップ/中小企業の競合リーダーシップマッピング
  • 不妊治療市場の上位企業のフットプリント分析
  • 競合シナリオ

第12章 企業プロファイル

  • 主要企業
    • THE COOPER COMPANIES INC.
    • COOK GROUP
    • VITROLIFE
    • THERMO FISHER SCIENTIFIC
    • HAMILTON THORNE LTD.
    • ESCO MICRO PTE. LTD.
    • GENEA LIMITED
    • IVFTECH APS
    • FUJIFILM IRVINE SCIENTIFIC
    • THE BAKER COMPANY, INC.
    • KITAZATO CORPORATION
    • ROCKET MEDICAL PLC
    • IHMEDICAL A/S
    • ZEISS GROUP
    • MEDGYN PRODUCTS, INC.
  • その他の企業
    • DXNOW, INC.
    • NIDACON INTERNATIONAL AB
    • GYNOTEC B.V.
    • SAR HEALTHLINE PVT. LTD.
    • INVITROCARE INC.

第13章 付録

目次
Product Code: MD 3765

The global infertility treatment market size is projected to reach USD 2.2 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 8.1 % during the forecast period. Factors such as decline in the fertility rates worldwide, increase adoption of different infertility procedures, rising number of fertility clinics worldwide, rise in public & private investments and presence of advanced infertility treatment products in the market are anticipated to boost the growth of the market.

The recent COVID-19 global pandemic has also impacted the infertility treatment market. Logistical issues, managing patients with the disease, prioritizing patients with comorbidities and pre-existing conditions, and protecting public & hospital frontline workers from exposure to the COVID-19 infection are the major challenges faced by healthcare systems across the globe. One in six reproductive-aged couples experiences infertility, and many turn to treatments such as intrauterine insemination (IUI) and in vitro fertilization (IVF), which require in-person appointments to complete. In India, 30 lakh people seek infertility treatment every year, but only 5 lakh people undergo IVF/intrauterine insemination (IUI) procedures. During the COVID-19 pandemic, a 90% drop was observed in the number of people undergoing IVF cycles. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also impacted fertility decisions among couples who were opting for IVF treatment before the pandemic.

"The equipment to capture the largest share in infertility treatment market, by products during the forecast period."

The equipment segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the technological advancements and presence of well-established players with strong product portfolio. Along with this growing focus of players towards base expansion through adopting various strategies such as new equipment launch, showcase across the globe is likely to contribute towards the growth of the segment.

"The assisted reproductive technology (ART) to capture the largest market share of infertility treatment market, by the procedure in 2021."

The assisted reproductive technology segment captured the largest share of the infertility treatment market procedures during the forecast period. The growing awareness of the presence of ART, rise in success rate of this procedure and growing worldwide acceptance of ART is likely to boost the growth of the segment.

"The female infertility treatment segment commanded for the largest share of the infertility treatment market, by patient type, in 2021"

The decreasing rates of fertility among females, growing availability of various fertility treatment options, and the increasing number of fertility centers across the globe are driving the growth of the female infertility treatment market.

"The fertility centers segment accounted for the largest share of the infertility treatment market, by end user, in 2021"

The rising government initiatives to establish fertility clinics, initiatives taken by large international healthcare providers to establish fertility centers, and the increasing popularity of IVF & ICSI treatment globally are some of the factors likely to contribute towards the rapid growth of the segment.

"The Asia Pacific market to grow at the highest CAGR during the forecast period."

The infertility treatment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Increase in the awareness of availability of infertility treatment procedures, growing fertility centers in the region, rising healthcare expenditures, increasing patient population, growing medical tourism, improving healthcare expenditure on infertility treatment, and initiatives by the government to increase the accessibility of the infertility treatment in the emerging nations.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
  • By Designation: C-level: 26%, D-level: 30%, and Others: 44%
  • By Region: North America: 40%, Europe: 31%, APAC: 20%, Latin America: 6%, and the Middle East & Africa: 3%

The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US).

Research Coverage

This report studies the global infertility treatment market based on the product, procedure, patient type, end users, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the global infertility treatment market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 MAJOR MARKET STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARIES: INFERTILITY TREATMENT MARKET
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.2 USAGE-BASED MARKET ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: INFERTILITY TREATMENT MARKET BASED ON PRODUCT UTILIZATION METHODOLOGY
    • FIGURE 5 MARKET SIZE ESTIMATION: INFERTILITY TREATMENT MARKET BASED ON REVENUE MAPPING METHODOLOGY
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
    • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 7 INFERTILITY TREATMENT MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 8 INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 9 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 10 INFERTILITY TREATMENT MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE INFERTILITY TREATMENT MARKET

4 PREMIUM INSIGHTS

  • 4.1 INFERTILITY TREATMENT MARKET OVERVIEW
    • FIGURE 12 DECLINING FERTILITY RATE AND RISING NUMBER OF FERTILITY CLINICS WORLDWIDE TO DRIVE MARKET GROWTH
  • 4.2 INFERTILITY TREATMENT MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 MEDIA & CONSUMABLES SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE INFERTILITY TREATMENT MARKET DURING THE FORECAST PERIOD
  • 4.3 INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 ASSISTED REPRODUCTIVE TECHNOLOGY IS THE LARGEST PROCEDURE SEGMENT OF THE INFERTILITY TREATMENT MARKET
  • 4.4 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 MALE INFERTILITY TREATMENT SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
  • 4.5 INFERTILITY TREATMENT MARKET SHARE, BY END USER, 2021
    • FIGURE 16 FERTILITY CENTERS ARE THE LARGEST END USERS OF INFERTILITY TREATMENT PRODUCTS
  • 4.6 ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PRODUCT AND COUNTRY (2021)
    • FIGURE 17 EQUIPMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE APAC INFERTILITY TREATMENT MARKET IN 2021
    • FIGURE 18 APAC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021-2026)

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 INFERTILITY TREATMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Declining fertility rate
    • FIGURE 20 DECLINING GLOBAL FERTILITY RATE, BY REGION, 1990 VS. 2019 VS. 2030
    • FIGURE 21 RISING OBESITY RATES (PERCENTAGE OF THE US POPULATION): 2010 VS. 2030
      • 5.2.1.2 Rising number of fertility clinics worldwide
      • 5.2.1.3 Technological advancements
        • 5.2.1.3.1 Advancements in infertility treatment devices
        • 5.2.1.3.2 Increasing use of time-lapse technology worldwide
      • 5.2.1.4 Increasing public-private investments, funds, and grants
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High costs associated with assisted reproductive technology in developed markets
    • TABLE 1 INFERTILITY TREATMENT COSTS
      • 5.2.2.2 Unsupportive government regulations
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging markets
        • 5.2.3.1.1 Improving healthcare infrastructure
      • 5.2.3.2 Increasing medical tourism due to low treatment costs
      • 5.2.3.3 Use of fertility treatment options by single parents and same-sex couples
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Concerns related to ART procedures
      • 5.2.4.2 Reduced efficacy among older women
  • 5.3 REGULATORY LANDSCAPE
    • 5.3.1 NORTH AMERICA
      • 5.3.1.1 US
      • 5.3.1.2 Canada
    • 5.3.2 EUROPE
    • 5.3.3 ASIA PACIFIC
      • 5.3.3.1 India
      • 5.3.3.2 Japan
    • TABLE 2 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • 5.4 COVID-19 IMPACT ON THE INFERTILITY TREATMENT MARKET
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 22 VALUE CHAIN OF THE INFERTILITY TREATMENT MARKET
  • 5.6 PRICING TREND ANALYSIS
    • TABLE 3 AVERAGE PRICE OF INFERTILITY TREATMENT EQUIPMENT AND MEDIA, BY COUNTRY, 2020 (USD)
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 INFERTILITY TREATMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • FIGURE 23 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • FIGURE 24 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF SUPPLIERS
    • FIGURE 25 BARGAINING POWER OF SUPPLIERS
    • 5.7.4 BARGAINING POWER OF BUYERS
    • FIGURE 26 BARGAINING POWER OF BUYERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
    • FIGURE 27 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 ECOSYSTEM COVERAGE

6 INFERTILITY TREATMENT MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 5 INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • 6.1.1 EQUIPMENT
    • TABLE 6 INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 7 INFERTILITY TREATMENT EQUIPMENT MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.2 MICROSCOPES
    • 6.2.1 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF MICROSCOPY HAS RESULTED IN THE GROWING ADOPTION OF MICROSCOPES
    • TABLE 8 MICROSCOPES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 9 MICROSCOPES MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 10 MICROSCOPES MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 11 MICROSCOPES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 6.2.2 IMAGING SYSTEMS
      • 6.2.2.1 Advantages offered by imaging systems in the field of infertility treatment are driving their adoption
    • TABLE 12 IMAGING SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 13 IMAGING SYSTEMS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 14 IMAGING SYSTEMS MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 15 IMAGING SYSTEMS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 6.2.3 SPERM ANALYZER SYSTEMS
      • 6.2.3.1 Sperm analyzer systems have a wide range of applications in fertility screening
    • TABLE 16 SPERM ANALYZER SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 17 SPERM ANALYZER SYSTEMS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 18 SPERM ANALYZER SYSTEMS MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 19 SPERM ANALYZER SYSTEMS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 6.2.4 OVUM ASPIRATION PUMPS
      • 6.2.4.1 Ovum aspiration pumps are widely used to retrieve and protect oocytes
    • TABLE 20 OVUM ASPIRATION PUMPS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 21 OVUM ASPIRATION PUMPS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 22 OVUM ASPIRATION PUMPS MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 23 OVUM ASPIRATION PUMPS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 6.2.5 MICROMANIPULATOR SYSTEMS
      • 6.2.5.1 Micromanipulator systems are used in cases pertaining to poor sperm quality/mobility
    • TABLE 24 MICROMANIPULATOR SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 25 MICROMANIPULATOR SYSTEMS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 26 MICROMANIPULATOR SYSTEMS MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 27 MICROMANIPULATOR SYSTEMS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 6.2.6 INCUBATORS
      • 6.2.6.1 Incubators play a vital role in embryo development and improved clinical outcomes
    • TABLE 28 INCUBATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 29 INCUBATORS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 30 INCUBATORS MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 31 INCUBATORS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 6.2.7 GAS ANALYZERS
      • 6.2.7.1 Gas analyzers contain multiple ports enabling analysis of sequential gas samples
    • TABLE 32 GAS ANALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 33 GAS ANALYZERS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 34 GAS ANALYZERS MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 35 GAS ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 6.2.8 LASER SYSTEMS
      • 6.2.8.1 Common applications of laser systems include the treatment of stress urinary incontinence and vaginal tightening
    • TABLE 36 LASER SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 37 LASER SYSTEMS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 38 LASER SYSTEMS MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 39 LASER SYSTEMS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 6.2.9 CRYOSYSTEMS
      • 6.2.9.1 Demand for cryosystems is on the rise as women are seeking to extend their childbearing years
    • TABLE 40 CRYOSYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 41 CRYOSYSTEMS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 42 CRYOSYSTEMS MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 43 CRYOSYSTEMS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 6.2.10 SPERM SEPARATION DEVICES
      • 6.2.10.1 Introduction of advanced sperm separation devices to boost their adoption
    • TABLE 44 SPERM SEPARATION DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 45 SPERM SEPARATION DEVICES MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 46 SPERM SEPARATION DEVICES MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 47 SPERM SEPARATION DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 6.3 MEDIA & CONSUMABLES
    • 6.3.1 EASY AVAILABILITY OF CULTURE MEDIA TO SUPPORT MARKET GROWTH
    • TABLE 48 INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 49 INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 50 INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 51 INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 6.4 ACCESSORIES
    • 6.4.1 ANTI-VIBRATION TABLES ARE COMMONLY USED FOR IVF TREATMENTS TO PROVIDE A SMOOTH WORKSPACE DURING PROCEDURES
    • TABLE 52 INFERTILITY TREATMENT ACCESSORIES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 53 INFERTILITY TREATMENT ACCESSORIES MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 54 INFERTILITY TREATMENT ACCESSORIES MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 55 INFERTILITY TREATMENT ACCESSORIES MARKET, BY END USER, 2019-2026 (USD MILLION)

7 INFERTILITY TREATMENT MARKET, BY PROCEDURE

  • 7.1 INTRODUCTION
    • TABLE 56 INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
  • 7.2 ASSISTED REPRODUCTIVE TECHNOLOGY
    • TABLE 57 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 58 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.2.1 IN VITRO FERTILIZATION
    • FIGURE 28 UK: IVF BIRTH RATES, 2010-2019
    • TABLE 59 IN VITRO FERTILIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 60 IN VITRO FERTILIZATION MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 7.2.1.1 Intracytoplasmic morphologically selected sperm injection
        • 7.2.1.1.1 IMSI is highly recommended in patients with a low sperm count and recurrent implantation failure
    • TABLE 61 INTRACYTOPLASMIC MORPHOLOGICALLY SELECTED SPERM INJECTION MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 7.2.1.2 Gamete donation
        • 7.2.1.2.1 Increasing number of women registering as egg donors is a key factor aiding market growth
    • TABLE 62 GAMETE DONATION MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.2.2 INTRACYTOPLASMIC SPERM INJECTION
      • 7.2.2.1 ICSI is a specialized form of IVF involving fertilization used commonly in male infertility treatment procedures
    • TABLE 63 INTRACYTOPLASMIC SPERM INJECTION MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.2.3 SURROGACY
      • 7.2.3.1 High success rates guaranteed and achieved with the help of surrogacy are driving market growth
    • TABLE 64 SURROGACY MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 ARTIFICIAL INSEMINATION
    • TABLE 65 ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 66 ARTIFICIAL INSEMINATION MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.3.1 INTRAUTERINE INSEMINATION
      • 7.3.1.1 Limited risk of complications during pregnancy and high success rate are driving the market for IUI procedures
    • TABLE 67 INTRAUTERINE INSEMINATION MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.3.2 INTRACERVICAL INSEMINATION
      • 7.3.2.1 Low cost of this procedure as compared to other AI procedures to support market growth
    • TABLE 68 INTRACERVICAL INSEMINATION MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.3.3 INTRATUBAL INSEMINATION
      • 7.3.3.1 High cost and uncertain success rate of this procedure to restrain the market growth
    • TABLE 69 INTRATUBAL INSEMINATION MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 FERTILITY SURGERIES
    • TABLE 70 FERTILITY SURGERIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 71 FERTILITY SURGERIES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.4.1 LAPAROSCOPY
      • 7.4.1.1 Laparoscopy allows for the biopsy of suspect growths and cysts that hamper fertility
    • TABLE 72 LAPAROSCOPY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.4.2 HYSTEROSCOPY
      • 7.4.2.1 Growing demand for minimally invasive procedures is driving the adoption of hysteroscopy infertility treatment surgeries globally
    • TABLE 73 HYSTEROSCOPY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.4.3 MYOMECTOMY
      • 7.4.3.1 Advantages of myomectomy in alleviating problems caused due to fibroids while preserving future fertility to drive the demand for this surgery
    • TABLE 74 MYOMECTOMY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.4.4 LAPAROTOMY
      • 7.4.4.1 Laparotomy is used in common infertility surgeries that require large exposure to the reproductive system
    • TABLE 75 LAPAROTOMY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.4.5 TUBAL LIGATION REVERSAL
      • 7.4.5.1 Tubal ligation reversal is performed in women who still have a large portion of healthy fallopian tube remaining
    • TABLE 76 TUBAL LIGATION REVERSAL MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.4.6 VARICOCELECTOMY
      • 7.4.6.1 Varicocelectomy results in a high chance of improved fertility with reduced complications
    • TABLE 77 VARICOCELECTOMY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.4.7 MICROSURGICAL RECONSTRUCTION
    • TABLE 78 MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 79 MICROSURGICAL RECONSTRUCTION MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 7.4.7.1 Vasovasostomy
        • 7.4.7.1.1 Vasovasostomy is a reversal surgery commonly used in the treatment of infertility in men
    • TABLE 80 VASOVASOSTOMY MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 7.4.7.2 Vasoepididymostomy
        • 7.4.7.2.1 Vasoepididymostomy provides a higher pregnancy rate than IVF with ICSI
    • TABLE 81 VASOEPIDIDYMOSTOMY MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.5 OTHER INFERTILITY TREATMENT PROCEDURES
    • TABLE 82 OTHER INFERTILITY TREATMENT PROCEDURES MARKET, BY REGION, 2019-2026 (USD MILLION)

8 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE

  • 8.1 INTRODUCTION
    • TABLE 83 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
  • 8.2 FEMALE INFERTILITY TREATMENT
    • 8.2.1 INCREASING FEMALE INFERTILITY RATES TO DRIVE THE GROWTH OF THE FEMALE INFERTILITY TREATMENT MARKET
    • FIGURE 29 US: IVF SUCCESS RATES BY AGE FOR ALL IVF CYCLES, 2019
    • TABLE 84 FEMALE INFERTILITY TREATMENT MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 MALE INFERTILITY TREATMENT
    • 8.3.1 GROWING ADOPTION OF MALE INFERTILITY TREATMENT PROCEDURES TO DRIVE MARKET GROWTH
    • TABLE 85 MALE INFERTILITY TREATMENT MARKET, BY REGION, 2019-2026 (USD MILLION)

9 INFERTILITY TREATMENT MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 86 INFERTILITY TREATMENT MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.2 FERTILITY CENTERS
    • 9.2.1 GROWING NUMBER OF INFERTILITY TREATMENT CENTERS WORLDWIDE TO DRIVE MARKET GROWTH
    • TABLE 87 INFERTILITY TREATMENT MARKET FOR FERTILITY CENTERS, BY REGION, 2019-2026 (USD MILLION)
  • 9.3 HOSPITALS & SURGICAL CLINICS
    • 9.3.1 GOVERNMENT INITIATIVES TO INCREASE HOSPITALS EQUIPPED TO PERFORM INFERTILITY TREATMENT PROCEDURES IS SUPPORTING MARKET GROWTH
    • TABLE 88 INFERTILITY TREATMENT MARKET FOR HOSPITALS & SURGICAL CLINICS, BY REGION, 2019-2026 (USD MILLION)
  • 9.4 CRYOBANKS
    • 9.4.1 INCREASING NUMBER OF ART PROCEDURES USING DONOR SPERM AND DONOR EGGS FOR INFERTILITY TREATMENT TO DRIVE MARKET GROWTH
    • TABLE 89 INFERTILITY TREATMENT MARKET FOR CRYOBANKS, BY REGION, 2019-2026 (USD MILLION)
  • 9.5 RESEARCH INSTITUTES
    • 9.5.1 GROWING NEED FOR IMPROVING THE CLINICAL EFFICACY OF VARIOUS INFERTILITY TREATMENT OPTIONS TO DRIVE MARKET GROWTH
    • TABLE 90 INFERTILITY TREATMENT MARKET FOR RESEARCH INSTITUTES, BY REGION, 2019-2026 (USD MILLION)

10 INFERTILITY TREATMENT MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 91 INFERTILITY TREATMENT MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 10.2 ASIA PACIFIC
    • TABLE 93 ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 94 ASIA PACIFIC: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 96 ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 97 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 98 ASIA PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 99 ASIA PACIFIC: FERTILITY SURGERIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 100 ASIA PACIFIC: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 101 ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 102 ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.1 CHINA
      • 10.2.1.1 Declining birth rate in China to drive the demand for infertility treatment procedures in the country
    • TABLE 103 CHINA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 104 CHINA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.2.2 JAPAN
      • 10.2.2.1 Growing awareness has served to boost the adoption of IVF procedures in Japan
    • TABLE 105 JAPAN: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 106 JAPAN: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.2.3 INDIA
      • 10.2.3.1 Rising medical tourism to offer high-growth opportunities for players in the Indian infertility treatment market
    • TABLE 107 INDIA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 108 INDIA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.2.4 AUSTRALIA
      • 10.2.4.1 Initiatives by the Australian government to support market growth
    • TABLE 109 AUSTRALIA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 110 AUSTRALIA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.2.5 SOUTH KOREA
      • 10.2.5.1 Supportive government initiatives will positively impact market growth
    • TABLE 111 SOUTH KOREA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 112 SOUTH KOREA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.2.6 REST OF ASIA PACIFIC
    • TABLE 113 ROAPAC: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 114 ROAPAC: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 115 EUROPE: INFERTILITY TREATMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 116 EUROPE: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 117 EUROPE: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 118 EUROPE: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 119 EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 120 EUROPE: IN VITRO FERTILIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 121 EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 122 EUROPE: FERTILITY SURGERIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 123 EUROPE: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 124 EUROPE: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 125 EUROPE: INFERTILITY TREATMENT MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Favorable funding scenario for IVF treatments in Germany to drive market growth
    • TABLE 126 GERMANY: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 127 GERMANY: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Supportive regulatory framework in the UK to drive market growth
    • FIGURE 31 UK: NUMBER OF IVF CYCLES BY EGG AND SPERM SOURCE, 2010-2019
    • TABLE 128 UK: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 129 UK: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Rising healthcare spending in France to drive market growth
    • TABLE 130 FRANCE: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 131 FRANCE: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Decreasing fertility rates to drive the demand for fertility testing treatment procedures in Italy
    • TABLE 132 ITALY: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 133 ITALY: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Spain is an established destination for IVF tourism
    • TABLE 134 SPAIN: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 135 SPAIN: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 136 ROE: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 137 ROE: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 10.4 NORTH AMERICA
    • TABLE 138 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 139 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 140 NORTH AMERICA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 141 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 142 NORTH AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 143 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 144 NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 145 NORTH AMERICA: FERTILITY SURGERIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 146 NORTH AMERICA: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 147 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 148 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.1 US
      • 10.4.1.1 The US dominates the infertility treatment market in North America
    • TABLE 149 US: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 150 US: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.4.2 CANADA
      • 10.4.2.1 High cost of infertility treatment in the country to restrain the market growth
    • TABLE 151 CANADA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 152 CANADA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 153 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 154 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 155 LATIN AMERICA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 156 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 157 LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 158 LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 159 LATIN AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 160 LATIN AMERICA: FERTILITY SURGERIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 161 LATIN AMERICA: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 162 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 163 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Brazil holds the largest share of the Latin American infertility treatment market
    • TABLE 164 BRAZIL: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 165 BRAZIL: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Growth in medical tourism is a key factor driving market growth
    • TABLE 166 MEXICO: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 167 MEXICO: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • TABLE 168 ROLATAM: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 169 ROLATAM: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 RISING INCIDENCE OF INFERTILITY TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
    • TABLE 170 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 171 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 172 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 173 MIDDLE EAST & AFRICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 174 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 175 MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 176 MIDDLE EAST & AFRICA: FERTILITY SURGERIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 177 MIDDLE EAST & AFRICA: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 178 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2019-2026 (USD MILLION)
    • TABLE 179 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY END USER, 2019-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES
  • 11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
    • FIGURE 32 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE INFERTILITY TREATMENT MARKET
  • 11.4 MARKET SHARE ANALYSIS (2020)
    • TABLE 180 INFERTILITY TREATMENT MARKET: DEGREE OF COMPETITION
  • 11.5 COMPETITIVE LEADERSHIP MAPPING
    • 11.5.1 STARS
    • 11.5.2 PERVASIVE PLAYERS
    • 11.5.3 EMERGING LEADERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 33 INFERTILITY TREATMENT MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
  • 11.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2020)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 34 INFERTILITY TREATMENT MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2020
  • 11.7 FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE INFERTILITY TREATMENT MARKET
    • 11.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE INFERTILITY TREATMENT MARKET
    • TABLE 181 PRODUCT FOOTPRINT OF COMPANIES
  • 11.8 COMPETITIVE SCENARIO
    • 11.8.1 INFERTILITY TREATMENT MARKET: PRODUCT LAUNCHES AND REGULATORY APPROVALS
    • TABLE 183 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS, JANUARY 2018-SEPTEMBER 2021
    • 11.8.2 INFERTILITY TREATMENT MARKET: DEALS
    • TABLE 184 KEY DEALS, JANUARY 2018-SEPTEMBER 2021
    • 11.8.3 INFERTILITY TREATMENT MARKET: OTHER DEVELOPMENTS
    • TABLE 185 OTHER KEY DEVELOPMENTS, JANUARY 2018-SEPTEMBER 2021

12 COMPANY PROFILES

  • 12.1 MAJOR PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 12.1.1 THE COOPER COMPANIES INC.
    • TABLE 186 THE COOPER COMPANIES INC.: BUSINESS OVERVIEW
    • FIGURE 35 THE COOPER COMPANIES INC.: COMPANY SNAPSHOT (2020)
    • TABLE 187 THE COOPER COMPANIES, INC.: PRODUCT OFFERINGS
    • 12.1.2 COOK GROUP
    • TABLE 188 COOK GROUP: BUSINESS OVERVIEW
    • TABLE 189 COOK GROUP: PRODUCT OFFERINGS
    • 12.1.3 VITROLIFE
    • TABLE 190 VITROLIFE: BUSINESS OVERVIEW
    • FIGURE 36 VITROLIFE: COMPANY SNAPSHOT (2020)
    • TABLE 191 VITROLIFE: PRODUCT OFFERINGS
    • 12.1.4 THERMO FISHER SCIENTIFIC
    • TABLE 192 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 37 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
    • TABLE 193 THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS
    • 12.1.5 HAMILTON THORNE LTD.
    • TABLE 194 HAMILTON THORNE LTD.: BUSINESS OVERVIEW
    • FIGURE 38 HAMILTON THORNE LTD.: COMPANY SNAPSHOT (2020)
    • TABLE 195 HAMILTON THORNE LTD.: PRODUCT OFFERINGS
    • 12.1.6 ESCO MICRO PTE. LTD.
    • TABLE 196 ESCO MICRO PTE. LTD.: BUSINESS OVERVIEW
    • TABLE 197 ESCO MICRO PTE. LTD.: PRODUCT OFFERINGS
    • 12.1.7 GENEA LIMITED
    • TABLE 198 GENEA LIMITED: BUSINESS OVERVIEW
    • TABLE 199 GENEA LIMITED: PRODUCT OFFERINGS
    • 12.1.8 IVFTECH APS
    • TABLE 200 IVFTECH APS: BUSINESS OVERVIEW
    • TABLE 201 IVFTECH APS: PRODUCT OFFERINGS
    • 12.1.9 FUJIFILM IRVINE SCIENTIFIC
    • TABLE 202 FUJIFILM IRVINE SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 39 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020)
    • TABLE 203 FUJIFILM IRVINE SCIENTIFIC: PRODUCT OFFERINGS
    • 12.1.10 THE BAKER COMPANY, INC.
    • TABLE 204 THE BAKER COMPANY, INC.: BUSINESS OVERVIEW
    • TABLE 205 THE BAKER COMPANY, INC.: PRODUCT OFFERINGS
    • 12.1.11 KITAZATO CORPORATION
    • TABLE 206 KITAZATO CORPORATION: BUSINESS OVERVIEW
    • TABLE 207 KITAZATO CORPORATION: PRODUCT OFFERINGS
    • 12.1.12 ROCKET MEDICAL PLC
    • TABLE 208 ROCKET MEDICAL PLC: BUSINESS OVERVIEW
    • TABLE 209 ROCKET MEDICAL PLC: PRODUCT OFFERINGS
    • 12.1.13 IHMEDICAL A/S
    • TABLE 210 IHMEDICAL A/S: BUSINESS OVERVIEW
    • TABLE 211 IHMEDICAL A/S: PRODUCT OFFERINGS
    • 12.1.14 ZEISS GROUP
    • TABLE 212 ZEISS GROUP: BUSINESS OVERVIEW
    • FIGURE 40 ZEISS GROUP: COMPANY SNAPSHOT (2020)
    • TABLE 213 ZEISS GROUP: PRODUCT OFFERINGS
    • 12.1.15 MEDGYN PRODUCTS, INC.
    • TABLE 214 MEDGYN PRODUCTS, INC.: BUSINESS OVERVIEW
    • TABLE 215 MEDGYN PRODUCTS, INC.: PRODUCT OFFERINGS
  • 12.2 OTHER PLAYERS
    • 12.2.1 DXNOW, INC.
    • 12.2.2 NIDACON INTERNATIONAL AB
    • 12.2.3 GYNOTEC B.V.
    • 12.2.4 SAR HEALTHLINE PVT. LTD.
    • 12.2.5 INVITROCARE INC.
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS